On December 7, 2017, Eriksen, Birgitte Langer; Gustafsson, Magnus; Hougaard, Charlotte; Jacobsen, Thomas Amos; Jefson, Martin R.; Klein, Jessica; Larsen, Janus Schreiber; Lowe, John A., III; McCall, John M.; Strooebaek, Dorte; Von Schoubye, Nadia Lyboel; Keaney, Gregg F. published a patent.Safety of 5-Methoxy-1H-pyrazole The title of the patent was Preparation of cycloalkylamino nitrogen heterocycles as potassium channel modulators for the treatment and prevention of disorders. And the patent contained the following:
The invention relates to preparation of cycloalkylamino nitrogen heterocycles of formula I wherein all the variables are as defined in the disclosure, and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the compounds I pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels. The experimental process involved the reaction of 5-Methoxy-1H-pyrazole(cas: 215610-30-3).Safety of 5-Methoxy-1H-pyrazole
The Article related to cycloalkylamino nitrogen heterocycle potassium channel modulator disease treatment prophylaxis, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Safety of 5-Methoxy-1H-pyrazole
Referemce:
Pyrazole – Wikipedia,
Pyrazoles – an overview | ScienceDirect Topics